1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup
(
- Contribution to journal › Article
- 2015
-
Mark
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging
(
- Contribution to conference › Abstract
-
Mark
Cabozantinib Resolves Bone Scans in Tumor-Naive Mice Harboring Skeletal Injuries
(
- Contribution to journal › Article
-
Mark
Molecular Imaging for Localized Prostate Cancer: Analysis of 2 Prospective Phase 0 Trials of PSMA Targeted Immuno-PET and –SPECT, and Implications for the Radiation Oncologist
2014) American Society for Radiation Oncology (ASTRO) 56th Annual Meeting In International Journal of Radiation Oncology Biology Physics 90(1 Suppl). p.208-208(
- Contribution to journal › Published meeting abstract
-
Mark
A Comparison of 111In-J591 SPECT with 89Zr-J591 PET Imaging for Prostate Cancer Patients
2014) American Urological Association (AUA) Annual Meeting In The Journal of urology 191(S4). p.602-603(
- Contribution to journal › Published meeting abstract
-
Mark
Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer : Implications for defining postradiotherapy urinary toxicity
(
- Contribution to journal › Article